Biopharma M&A set for a strong H2 despite political noise—and Biogen and Gilead look like ...

Retrieved on: 2021-06-28 14:03:45

Tags for this article:

Life Sciences

Companies

Södertälje Municipality

Kite Pharma

Special-purpose acquisition company

Bristol-Myers Squibb

Johnson & Johnson

William Whelan

Click the tags to see associated articles and topics

Biopharma M&A set for a strong H2 despite political noise—and Biogen and Gilead look like .... View article details on hiswai:

Excerpt

In addition to pursuing hot assets in oncology and gene and cell therapy, biopharma dealmakers are embracing alternative financing strategies, such ...

Article found on: www.fiercepharma.com

View Original Article